Electrical cardioversion and myocardial injury: Evaluation by new cardiac injury markers

Arquivos Brasileiros de Cardiologia

Volumn 86, Issue 3, 2006, Pages 191-197

  Dos Santos, Elizabete Silva Dos ^a,b   Pereira, Marcos Paulo ^a   Minuzzo, Luiz ^a   Moreira, Dalmo A R ^a   Ramos, Rui ^a   Avezum, Álvaro ^a   Timerman, Ari ^a   Piegas, Leopoldo ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiac troponin I; Cardioversion; Myocardial injury

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVERSION; CREATINE KINASE BLOOD LEVEL; DISEASE MARKER; ENERGY; ENZYME ACTIVITY; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INJURY; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; ANALYSIS OF VARIANCE; BLOOD; MIDDLE AGED; TIME;

ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; ELECTRIC COUNTERSHOCK; FEMALE; HEART INJURIES; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; TIME FACTORS; TROPONIN I;

EID: 33645657382     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Neumayr G, Hagn C, Gänzer H et al. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. The American Journal of Cardiology 1997; 80: 1367-9.
2. Beck CS, Pritchard VM, Feil HS. Ventricular fibrillation of long duration abolished by electric shock. JAMA 1947; 135: 985-90.
3. Warner ED, Dahl C, Ewy GA. Myocardial injury from transthoracic defibrillator countershock. Arch Pathol 1975; 99: 55-60.
4. Trouton TG, Allen JD, Adgey AA. Oxidative metabolism and myocardial blood flow change after transthoracic DC countershocks in dogs. Eur Heart J 1992; 13: 1431-40.
5. Reiffel YA, McCarthy DM, Leahey EB. Does DC conversion affect isoenzyme recognition of myocardial infarction? Am Heart J 1979; 97: 269-75.
6. Stabilini R, Agostini A, Berli GC et al. Serum myoglobin, total CK, and MB CK isoenzyme after DC cardioversion and during the early phase of acute myocardial infarction. Acta Cardiol 1980; 5: 373-80.
7. Eshani A, Gordon AE, Sobel BE. Effects of electrical countershock on serum creatine phosphokinase (total CPK) isoenzime activity. Am J Cardiol 1976; 37: 12-8.
8. Dahl CF, Ewy GA, Warner ED. Myocardial necrosis from direct current countershock: effect of paddle size and time interval between discharges. Circulation 1974; 50: 956-61.
9. Dalzell GWN, Cunningham SR, Anderson J et al. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. Am J Cardiol 1989; 64: 741-4.
10. Moak JP. Acute nonpharmacologic treatment of tachyarrhythmias and bradyarrhythmias in pediatric arrhythmias. In Gillette PC, Garson A, (ed.) Electrophysiology and pacing. Philadelphia: WB Saunders, 1990: 516-28.
11. Morrow DA, Antman EM. Cardiac marker elevation after cardioversion: sorting out chicken and egg. Eur Heart J 2000; 21: 171-3.
12. Del Rey JM, Madrid AH, Rubí J et al. Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions. Clin Chem 1998; 44: 2270-6.
13. Madrid AH, Sánchez JMR, Rebollo JMG et al. Correlación anatomopatológica y bioquímica de las lesiones producidas por la radiofrecuencia con catéteres estandar e irrigados de 4mm. Rev Esp Cardiol 2000; 53: 1347-55.
14. Madrid AH, Del Rey JM, Rubi J et al. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis. Am Heart J 1998; 136: 948-55.
15. Bonnefoy E, Chevalier P, Kirkorian G et al. Cardiac troponin I does not increase after cardioversion. Chest 1997; 111(1): 15-18.
16. Greaves K, Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 1998; 80: 226-8.
17. Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponins T and I after elective cardioversion. Eur Heart J 2000; 21: 245-52.
18. Runsio M, Kallner A, Kallner G, Rsenqvist M, Bergfeldt L. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin T release. Am J Cardiol 1997; 79: 1241-5.
19. Georges J, Spentchian M, Caubel C et al. Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol 1996; 78: 825-7.
20. Sánchez JMR, Madrid AH, Rebollo JMG et al. Cardioversion eléctrica externa y sistemas de cardioversión interna: evaluación prospectiva y comparativa del daño celular con troponina I. Rev Esp Cardiol 2002; 55(3): 227-34.
21. Trouton T, Allen I, Adgey A. Oxidative metabolism and myocardial blood flow changes after transthoracic DC countershocks in dogs. Eur Heart J 1992;13:1431-40.
22. Zabel M, Kaster W, Hohnloser H. Usefulness of CK-MB and troponin T determinations in patients with acute myocardial infartion complicated by ventricular fibrillation. Clin Cardiol 1991; 16: 23-5.
23. Corbitt JD Jr, Sybers J, Levin JM. Muscle changes of the anterior chest wall secondary to electrical countershock. Am J Clin Pathol 1969; 51: 107-12.
24. Kosior D, Chwyczko T, Stawicki S et al. Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillation. Pol Arch Med Wewn 2003; 110(2): 827-36.
25. Carunchio A, Burattini M, Coletta C et al. Electrical cardioversion for atrial fibrillation: advantages of the transthoracic biphasic method. Ital Heart J Suppl 2002; 3(6): 638-45.
26. Kosior DA, Opolski G, Tadeusiak W et al. Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2005; 28(Suppl 1): S128-32.
27. Adams 3D JE, Boder GS, Davila-Roman VG et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88(1): 101-6.
28. Pinto IM, Da luz PL, Magalhães HM et al. Consensos sobre métodos em cardiologia. Arq Bras Cardiol 1995; 65: 446-68.
29. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of Cardiac Magnetic Resonance Imaging in the Assesment of Myocardiol Viability. Circulation 2004; 109: 1328-34.